Rchr
J-GLOBAL ID：201801002560626089   Update date: Nov. 20, 2024

Nakamura Shingen

Nakamura Shingen
Affiliation and department：
Department of Community Medicine and Medical Science, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.

About Department of Community Medicine and Medical Science, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.


Research theme for competitive and other funds  (5)：
  • 2019 - 2023 がん化学療法後の全身性免疫炎症病態へのFusobacteriumの役割の解明
  • 2016 - 2018 Molecular mechanisms of activated osteoblast-induced myeloma death through mitochondrial impairment and metabolic perturbation
  • 2014 - 2016 Exploration of mechanism of drug resisitance in cancer acidic condition and development of novel therapeutic drug
  • 2013 - 2015 Targeting myeloma progenitors by ex vivo-expanded gamma delta T cell
  • 2013 - 2014 骨形成誘導と骨破壊性腫瘍の進展抑制を併せ持つ新たな分子標的薬の開発
Papers (161)：
  • Maeda Yusaku, Takao Shoichiro, Morita Shiori, Kondo Shin, Yamashita Michiko, Sumitani Ryohei, Oura Masahiro, Sogabe Kimiko, Takahashi Mamiko, Fujii Shiroh, et al. Quality of skeletal muscles during allogeneic stem-cell transplantation: a pilot study. BMJ Supportive & Palliative Care. 2024
  • Hori Taiki, Aihara Ken-ichi, Watanabe Takeshi, Inaba Kaori, Inaba Keisuke, Kaneko Yousuke, Kawata Saki, Kawahito Keisuke, Kita Hiroki, Shimizu Kazuma, et al. The Respiratory Adjusted Shock Index at Admission Is a Valuable Predictor of In-Hospital Outcomes for Elderly Emergency Patients with Medical Diseases at a Japanese Community General Hospital. Journal of Clinical Medicine. 2024. Vol.13. No.16
  • Takahashi Mamiko, Kondo Shin, Kagawa Kumiko, Nakamura Masafumi, Maeda Yusaku, Sumitani Ryohei, Yagi Hikaru, Oura Masahiro, Sogabe Kimiko, Harada Takeshi, et al. Skeletal muscle mass during chemotherapy for haematological malignancies: a retrospective study. BMJ Supportive & Palliative Care. 2024. Vol.14. No.2. 195-199
  • Hori Taiki, Shimizu Taro, ANDO Hidenori, Okada Naoto, Yamagami Hiroki, Yasui Saya, Hosoki Minae, Tojima Akihiro, Otoda Toshiki, Yuasa Tomoyuki, et al. Humoral immune response against SARS-CoV-2 and polyethylene glycol elicited by anti-SARS-CoV-2 mRNA vaccine, and effect of pre-existing anti-polyethylene glycol antibody in patients with hematological and autoimmune diseases. Heliyon. 2024. Vol.10. No.10. e31489-e31489
  • Nakamura Shingen, Hara Keijiro, Kobayashi Tomoko, Sumitani Ryohei, Oura Masahiro, Maeda Yusaku, Sogabe Kimiko, Yagi Hikaru, Takahashi Mamiko, Fujii Shiroh, et al. Tl uptake and retention mimicking malignant lymphoma in a patient with human immunodeficiency virus infection. Parasitology International. 2024. Vol.101. 102895-102895
ｍore...
MISC (155)：
  • Nakamura Shingen, Miki Hirokazu, Abe Masahiro. 【最新の骨粗鬆症学(第2版)-骨粗鬆症学の最新知見-】続発性骨粗鬆症の診断と治療 抗悪性腫瘍薬に伴う骨粗鬆症(解説). 日本臨床(0047-1852)81巻増刊1 最新の骨粗鬆症学 Page580-584(2023.01). 2023. Vol.81. 580-584
  • Nakamura Shingen, Miki Hirokazu, Abe Masahiro. 【骨髄腫と類縁疾患-全身をみわたす診断・治療】Overview 多発性骨髄腫の発症・進展機序. Internal Medicine. 2022. Vol.130. No.4. 691-694
  • Nakamura Shingen, Miki Hirokazu, Abe Masahiro. 【腎臓症候群(第3版)-その他の腎臓疾患を含めて-】各種病態にみられる腎障害 造血器疾患 多発性骨髄腫. Nihon Rinsho. Japanese Journal of Clinical Medicine. 2022. 124-130
  • 田中茉里子, 田中茉里子, 日浅雅博, 日浅雅博, 谷本幸多朗, 谷本幸多朗, 天真寛文, 天真寛文, 清水宗, 清水宗, et al. 不動は骨髄腫骨病変部DPP-4発現増加と骨髄腫の腫瘍進展・髄外播種を加速させる. 日本骨代謝学会学術集会プログラム抄録集(CD-ROM). 2022. 40th
  • Takeshi Harada, Yusuke Inoue, Hirofumi Tenshin, Asuka Oda, Ryohei Sumitani, Masahiro Oura, Kimiko Sogabe, Shiro Fujii, Shingen Nakamura, Hirokazu Miki, et al. Novel strategy of elotuzumab and zoledronic acid with Th1-like gamma delta Tcells against myeloma. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2021. 21. S41-S42
ｍore...
Books (6)：
  • Analysis of long-term survivors with cardiac AL amyloidosis
    The Japanese Society of Hematology 2017
  • Management of bone disease in myeloma patients: zoledronic acid or denosumab?
    The Japanese Society of Hematology 2015
  • アミロイドーシス効果判定基準 効果判定基準 2005コンセンサスクライテリア,2011新基準.ALアミロイドーシス,多発性骨髄腫の類縁疾患
    Iyaku Journal Co., Ltd. 2014
  • 臓器移植.ALアミロイドーシス,多発性骨髄腫の類縁疾患
    Iyaku Journal Co., Ltd. 2014
  • (chapter6)
    2014
ｍore...
Lectures and oral presentations  (312)：
  • 治療過程にある多発性骨髄腫患者が治療を続ける意味
    (第39回日本がん看護学会学術集会 2025)
  • False-positive aspergillus galactomannan test in multiple myeloma
    (ID week 2024 2024)
  • 来院時心肺停止・死亡転帰患者の臨床背景における糖尿病有無の影響に関する検討
    (第24回日本内分泌学会四国支部学術集会 2024)
  • 2型糖尿病患者の推定食塩摂取量と糖尿病性腎臓病指標の連関解析
    (第67回日本糖尿病学会年次学術集会 2024)
  • 2型糖尿病患者におけるdehydroepiandrosterone sulfate(DHEAS)と尿中アルブミン,尿中L型脂肪酸結合蛋白(L-FABP)との関連
    (第67回日本糖尿病学会年次学術集会 2024)
ｍore...
Committee career (7)：
  • 2016/04 - 現在 The Japanese Society of Gastroenterology 専門医
  • 2016/01 - 現在 日本血液学会 専門医・指導医
  • 2012/04 - 現在 日本臨床腫瘍学会 がん薬物療法専門医・指導医
  • - 現在 日本化学療法学会 抗菌化学療法認定医・指導医
  • - 現在 日本輸血細胞治療学会 細胞治療認定管理師
Show all
Awards (20)：
  • 2019/07/26 - Japanese Society for Bone and Mineral Research 第36回日本骨代謝学会学術集会 研究奨励賞. カテプシンK阻害による多発性骨髄腫骨病変部の骨量回復プロセスにおける骨細胞の役割
  • 2019/05/12 - 日本骨髄腫学会 日本骨髄腫学会 優秀ポスター賞 多発性骨髄腫患者におけるPIM2, TAK1 の重要性
  • 2018/11/23 - Esmo asia Esmo asia travel grant 2018 Alteration of muscle mass after chemotherapy in patients with newly diagnosed multiple myeloma.
  • 2018/10 - ESMO asia 2018 トラベルグラント
  • 2017/06/17 - Australian and New Zealand Bone and Mineral Society ANZBMS Plenary Poster Award. Osteoclasts utilize TRAIL for their NF-B activation, but TAK1 inhibition resumes TRAIL-induced apoptosis in osteoclasts.
Show all
Association Membership(s) (8)：
Japanese Society of Chemotherapy ,  日本骨髄腫学会 ,  The Japanese Association for Infectious Diseases ,  The Japanese Society of Gastroenterology ,  日本血液学会 ,  日本臨床腫瘍学会 ,  The Japanese Society of Internal Medicine ,  日本エイズ学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM